Introduction Despite improvements in medical science and public health, mortality of
community-acquired pneumonia (CAP) has barely changed throughout the last 15 years …

Background: Pneumonia is a common respiratory disease. In severe cases, it can induce
cardiovascular disease and even life-threatening. In particular, pneumonia caused by the …

Background Clinical antibiotic prescribing guidelines are essential in defining responsible
use in the local context. Our objective was to investigate the association between adherence …

Rationale The ratio of neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR) and
platelet-to-lymphocyte (PLR) are biomarkers that have shown potential for predicting …

Rationale: Care of emergency department (ED) patients with pneumonia can be
challenging. Clinical decision support may decrease unnecessary variation and improve …

Objectives To explore whether short-course antibiotic therapy is efficient and safe in routine
clinical settings among patients hospitalized with community-acquired pneumonia (CAP) …

Background Glycemic variability (GV) has only been sparsely studied in patients with
community-acquired pneumonia (CAP). This study aimed to quantify in-hospital GV in CAP …

Background Numerous studies have shown that the aetiology of community-acquired
pneumonia (CAP) varies considerably among different healthcare settings. Because empiric …

Background Community-acquired pneumonia (CAP) is the most frequent infection diagnosis
in hospitals. Antimicrobial therapy for CAP is depicted in clinical practice guidelines, but …

Hyperglycaemia is common in patients with community-acquired pneumonia (CAP) and is a
predictor of severe outcomes. Data are scarce regarding whether this association is affected …